PNV 2.35% $2.61 polynovo limited

The Clinicians Speak, page-1036

  1. 1,826 Posts.
    lightbulb Created with Sketch. 365

    It’s a constant refrain that I never tire of reading:

    ”BTM proved to be a versatile option for converting a complex wound to a superficial wound, and it abetted the drawbacks of a flap cover: extended hospital stay, discomfort, prolonged immobilization, and additional scars.”

 
watchlist Created with Sketch. Add PNV (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.